OMScience
Trump pays French company $1B to drop U.S. offshore wind energy in favour of fossil fuel projects.
www.npr.org/2026/03/23/g...
www.npr.org/2026/03/23/g...
Trump administration to pay French company $1B to drop U.S. offshore wind leases
TotalEnergies has agreed to what's essentially a refund of its leases for projects off the coasts of North Carolina and New York, and will invest the money in fossil fuel projects instead, the Departm...
www.npr.org
March 25, 2026 at 12:46 AM
OMScience
OMScience. Sick
February 12, 2026 at 7:13 PM
OMScience. Sick
👁 EYE-Q Answer Reveal! 👁
✅ Answer: D) All of the above
Ocular melanoma behaves differently biologically than cutaneous melanoma, including unique genetics and the eye’s immune environment.
#ACureInSight #EyeQ #OMScience #RareCancerResearch
✅ Answer: D) All of the above
Ocular melanoma behaves differently biologically than cutaneous melanoma, including unique genetics and the eye’s immune environment.
#ACureInSight #EyeQ #OMScience #RareCancerResearch
June 6, 2026 at 2:02 PM
👁 EYE-Q Answer Reveal! 👁
✅ Answer: D) All of the above
Ocular melanoma behaves differently biologically than cutaneous melanoma, including unique genetics and the eye’s immune environment.
#ACureInSight #EyeQ #OMScience #RareCancerResearch
✅ Answer: D) All of the above
Ocular melanoma behaves differently biologically than cutaneous melanoma, including unique genetics and the eye’s immune environment.
#ACureInSight #EyeQ #OMScience #RareCancerResearch
👁 EYE-Q Answer Reveal! 👁
✅ Answer: A) Predict or detect metastasis earlier
ctDNA research may one day help doctors monitor disease progression and detect metastasis sooner through blood testing.
#ACureInSight #EyeQ #OMScience #CancerResearch
✅ Answer: A) Predict or detect metastasis earlier
ctDNA research may one day help doctors monitor disease progression and detect metastasis sooner through blood testing.
#ACureInSight #EyeQ #OMScience #CancerResearch
July 18, 2026 at 2:02 PM
👁 EYE-Q Answer Reveal! 👁
✅ Answer: A) Predict or detect metastasis earlier
ctDNA research may one day help doctors monitor disease progression and detect metastasis sooner through blood testing.
#ACureInSight #EyeQ #OMScience #CancerResearch
✅ Answer: A) Predict or detect metastasis earlier
ctDNA research may one day help doctors monitor disease progression and detect metastasis sooner through blood testing.
#ACureInSight #EyeQ #OMScience #CancerResearch
👁 EYE-Q Answer Reveal! 👁
✅ Answer: B) Higher risk than Class 1A
Class 1B tumors carry a higher metastatic risk than Class 1A tumors, though generally lower than Class 2 tumors.
#ACureInSight #OMScience #EyeQ
✅ Answer: B) Higher risk than Class 1A
Class 1B tumors carry a higher metastatic risk than Class 1A tumors, though generally lower than Class 2 tumors.
#ACureInSight #OMScience #EyeQ
July 4, 2026 at 4:01 PM
👁 EYE-Q Answer Reveal! 👁
✅ Answer: B) Higher risk than Class 1A
Class 1B tumors carry a higher metastatic risk than Class 1A tumors, though generally lower than Class 2 tumors.
#ACureInSight #OMScience #EyeQ
✅ Answer: B) Higher risk than Class 1A
Class 1B tumors carry a higher metastatic risk than Class 1A tumors, though generally lower than Class 2 tumors.
#ACureInSight #OMScience #EyeQ
🎉 How Well Do You Know OM Genetics? 👁️
Question: Which mutations are most commonly found in uveal melanoma tumors?
A) BRCA1 & BRCA2
B) EGFR & ALK
C) GNAQ & GNA11
D) KRAS & NRAS
💬 This one’s tough 👀 Drop your guess!
#ACureInSight #EyeQ #OMScience
Question: Which mutations are most commonly found in uveal melanoma tumors?
A) BRCA1 & BRCA2
B) EGFR & ALK
C) GNAQ & GNA11
D) KRAS & NRAS
💬 This one’s tough 👀 Drop your guess!
#ACureInSight #EyeQ #OMScience
June 26, 2026 at 2:02 PM
🎉 How Well Do You Know OM Genetics? 👁️
Question: Which mutations are most commonly found in uveal melanoma tumors?
A) BRCA1 & BRCA2
B) EGFR & ALK
C) GNAQ & GNA11
D) KRAS & NRAS
💬 This one’s tough 👀 Drop your guess!
#ACureInSight #EyeQ #OMScience
Question: Which mutations are most commonly found in uveal melanoma tumors?
A) BRCA1 & BRCA2
B) EGFR & ALK
C) GNAQ & GNA11
D) KRAS & NRAS
💬 This one’s tough 👀 Drop your guess!
#ACureInSight #EyeQ #OMScience
👁 EYE-Q Answer Reveal! 👁
✅ Answer: B) Increased metastatic potential
PRAME is a biomarker that may indicate a higher risk of metastasis, even in tumors otherwise considered lower risk.
#ACureInSight #OMScience #EyeQ #OcularMelanoma
✅ Answer: B) Increased metastatic potential
PRAME is a biomarker that may indicate a higher risk of metastasis, even in tumors otherwise considered lower risk.
#ACureInSight #OMScience #EyeQ #OcularMelanoma
June 20, 2026 at 2:02 PM
👁 EYE-Q Answer Reveal! 👁
✅ Answer: B) Increased metastatic potential
PRAME is a biomarker that may indicate a higher risk of metastasis, even in tumors otherwise considered lower risk.
#ACureInSight #OMScience #EyeQ #OcularMelanoma
✅ Answer: B) Increased metastatic potential
PRAME is a biomarker that may indicate a higher risk of metastasis, even in tumors otherwise considered lower risk.
#ACureInSight #OMScience #EyeQ #OcularMelanoma
OMScience. #separationofchurchandstate
December 16, 2025 at 3:04 PM
OMScience. #separationofchurchandstate